The purpose of the present guidelines on the radioiodine therapy of differentiated thyroid cancer formulated by the European Association of Nuclear Medicine is to provide advice to nuclear medicine clinicians and other members of the DTC-treating community on how to ablate thyroid remnant or treat inoperable advanced DTC or both employing large 131-iodine (131I) activities.
